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ABSTRACT A 96-kDa protein predicted by the DNA
sequence of the Saccharomyces cerevisiae PRPS gene contains a
domain that bears a striking resemblance to a family of RNA
helicases characterized by the conserved amino acid sequence
Asp-Glu-Ala-Asp (D-E-A-D). Previous work indicated that the
product of the PRP5 gene is required for splicing and that
spliceosome assembly does not occur in its absence. However,
its precise role in splicing and the nature of its biochemical
activity remained unknown. To examine the role of PRP5 in
splicing, we cloned the gene by complementation of a temper-
ature-sensitive mutation and determined its DNA sequence. We
discuss here the possible roles for an RNA helicase in splicing
and for the activity of the PRP5 protein.
Splicing of introns from nuclear pre-mRNAs occurs by a
mechanism that appears to be common to most eukaryotes
and requires a complex trans-acting apparatus. Small nuclear
ribonucleoproteins (snRNPs) U1, U2, U4/U6, and U5 and a
number ofproteins assemble with a pre-mRNA substrate into
a large complex known as the spliceosome (reviewed in refs.
1-3). This assembly process and the subsequent excision of
the intron in the form of a lariat and ligation of the exons are
ATP dependent. Small nuclear RNAs (snRNAs) in the splice-
osome are thought to have a role in catalysis and in splice-site
recognition and alignment. A number ofthe protein factors as
well as the snRNA components of the spliceosome are
essential for nuclear splicing. The nuclear splicing mecha-
nism differs in this regard from the self-splicing mechanisms
it may have evolved from, which require cis-acting catalytic
RNA elements but no essential protein factors. Understand-
ing the role of proteins in splicing, therefore, not only will
provide better understanding of the nuclear splicing mecha-
nism itself but also may throw light on the pathway of
evolution from self-splicing to splicing mediated by a trans-
acting apparatus.
Identification of a number of proteins essential for nuclear
splicing has been greatly facilitated in the yeast Saccharo-
myces cerevisiae by the isolation of temperature-sensitive
(ts) mutants that affect pre-mRNA splicing. These mutants,
originally called rna mutants, have been renamed prp mu-
tants, for pre-RNA processing. In vitro biochemical studies
(4, 5) of the original set of mutants, prp2 to -11 (6), showed
that their gene products are directly involved in splicing. Of
these, the products of PRP3, -4, -5, -7, -8, and -11 are
required for spliceosome assembly (5), whereas the PRP2
product acts after a spliceosome forms but before any cova-
lent changes occur on the pre-mRNA substrate. Additional
prp mutants recently isolated (7) have novel phenotypes
which affect other late stages in splicing, including 3' splice
site cleavage and exon ligation, as well as degradation of the
lariat intron. Many of the PRP genes have been cloned
(8-11), and in all known cases they encode proteins. PRP4
and PRP8 are known to be snRNP proteins specifically
associated with U4/U6 and U5, respectively (12-14). Al-
though the step(s) of the splicing pathway affected by these
proteins are known, and some significant molecular interac-
tions have been identified, the nature of the biochemical
activity associated with these proteins is not understood.
We report here the finding that PRP5,* a protein directly
involved in nuclear splicing and spliceosome assembly, has a
central domain that is strikingly similar to the "D-E-A-D
family" RNA helicases, which share the sequence Asp-
Glu-Ala-Asp (D-E-A-D). Recently defined on the basis of
amino acid sequence similarity and shared biochemical prop-
erties, the RNA helicase family includes proteins found in
organisms ranging from Escherichia coli to humans, among
them the eukaryotic translation initiation factor 4A (eIF4A)
(15).
MATERIALS AND METHODS
Strains. S. cerevisiae strains SPJ 5.41 (a, his7, leu2, ura3-
52, prpS) and A364A (a, adel, ade2, lys2, tyri, his7, ural,
gall) were obtained from A. Lustig (Sloan-Kettering Cancer
Center, New York). S. cerevisiae 5.41::pGD561 (a, his7,
leu2) was constructed by chromosomal integration ofplasmid
pGD561, linearized with Sac I, into strain SPJ 5.41. Trans-
formation of yeast strains was by the lithium acetate method
(16).
E. coli strains used were DH5-a [08OdlacZA M15, endAl,
recAl, hsdRl7, supE44, thi-), gyrA, relAl, A(lacZYA-argF)
U169] and DH5-a F' [F', 080dlacZAM15, endAl, recAl,
hsdRJ7, supE44, thi-J, gyrA, relAl, A(lacZYA-argF)U169],
obtained from Bethesda Research Laboratories.
Plasmids and Library. YCp5O is a centromere-containing
yeast-E. coli shuttle vector derived from pBR322, which
confers ampicillin resistance to E. coli and carries the yeast
URA3, CEN4, and ARSJ genes. pSEYC68, obtained from S.
Emr (California Institute of Technology, Pasadena, CA), is
similar to YCp5O and contains, in addition, a copy of the E.
coli lacZ gene interrupted by a polylinker containing multiple
unique cloning sites. pGD551 is the original PRPS isolate
consisting of a 9-kilobase (kb) insert cloned in the YCp5O
BamHI site. YIp5 is a yeast integrating vector that carries the
yeast URA3 gene and confers ampicillin resistance to E. coli
(17). pGD561 consists of a 5.6-kb Pvu II-Cla I fragment that
complements the prpS ts defect, cloned in YIp5 between
unique Nru I and Cla I sites. The yeast genomic library
screened to isolate the PRPS gene, a gift from E. Phizicky
(University of Rochester, Rochester, NY), had been con-
structed by ligating yeast genomic DNA partially digested
with Sau3A into the BamHI site of YCp5O.
Cloning. A yeast genomic library, constructed in a cen-
tromere-containing vector which carries the yeast URA3
gene and confers ampicillin resistance to E. coli, was used to
Abbreviations: snRNP, small nuclear ribonucleoprotein; snRNA,
small nuclear RNA; eIF4A, eukaryotic translation initiation factor
4A; ts, temperature-sensitive.
*The sequence reported in this paper has been deposited in the
GenBank data base (accession no. M33191).
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transform a prpS ts strain, S. cerevisiae SPJ 5.41 by the
lithium acetate method (16). URA' transformants were se-
lected on agar plates of synthetic defined medium lacking
uracil, incubated at a permissive temperature (230C). These
transformants were replica plated onto fresh plates and
incubated at a nonpermissive temperature (350C) to select
temperature-resistant colonies. DNA was prepared from
resistant colonies and used to transform E. coli to ampicillin
resistance.
DNA Sequence Determination and Analysis. The sequence
of PRP5 was determined by the dideoxynucleotide method
(18).-A 3.0-kb HincII-Cla I fragment capable ofcomplement-
ing the PRPS ts defect was sequenced in both strands. A
3.9-kb EcoRI fragment cloned in M13 mpl8 containing the
entire HincII-Cla I fragment was sequenced in one orienta-
tion, using specific oligonucleotide primers (a to i). The
primers, derived from the sequence, were synthesized se-
quentially as it was determined (19). The sequence of the
opposite strand was determined on a double-stranded tem-
plate (pGD561), also using synthetic oligonucleotide primers
derived from the sequence (a' to i'). Sequence data were
assembled and analyzed initially using programs of the 1310-
NET National Computer Resource for Molecular Biology.
The assembly and analysis were completed by using the
University of Wisconsin Genetics Computer Group
(UWGCG) Sequence Analysis Software Package, version 6.1
(copyright 1989 by John R. Devereux), run on a VAXstation
2000 computer. Protein sequence data bases were searched
with the program FASTA (20); eIF4A was the highest-scoring
sequence in the National Biomedical Research Foundation
data base (release 22 of September 1989) with PRP5 as the
query sequence. The GenBank DNA sequence data base
(release 62.0 of December 1989) was searched with the
TFASTA (20) program, which translates the DNA sequences in
the data base in all six reading frames. Sequences not present
in these databases were compared to PRP5 by using the
UWGCG program BESTFIT and multiple sequences were
aligned with LINEUP.
Oligonucleotides. The following synthetic oligonucleotides,
shown schematically in Fig. 1, were used as DNA sequencing
primers: a, 5'-TGAGACTGTGGACGATTC; b, 5'-ATAGG-
GAGTCTTTATTG; c, 5'-TGACGTCATTGAAGGAG; d,
5'-GACTTAGTCTGGATAAT; e, 5'-ACGGCCATTATCA-
AACA; f, 5'-GAGATTGTTGTTGCCAC; g, 5'-GTTCGAT-
TTAGGY1TTG; h, 5'-GTGTCGTTGGTTATTATC; i, 5'-
GTTTATATTAATGAlfT; a', 5'-TCTACATCATATATT-
AT; b', 5'-CATGCTTGATAAATAATAAGGTTG; c', 5'-
CTCTGGCAGTTCTTCCAGTAGTAT; d', 5'-CTTCAACA-
TCGCTTGAC; e', 5'-TGTTCGGAAAAGTTGCACTAAA-
TAG; f', 5'-CTTCTGTGAATTTAGTA; g', 5'-TCCGTT-
GATAGTCCCAG; h', 5'-TCGTCGGTTCCTCCAAG; and
i', 5'-ACGTTCCTGTCTTTl-lCCG.
DNA Blot Analysis. Genomic yeast DNA was completely
digested with BstEII and Sal I and analyzed on 0.7% agarose
gels. DNA was transferred to a GeneScreen membrane
(NEN) according to the manufacturer's instructions. Probes
were prepared by radiolabeling gel-purified DNA fragments
by the random primer method (21). Prehybridization was
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FIG. 1. Schematic representation of the complementing HinclI-
Cla I fragment, showing the relative positions of the oligodeoxynu-
cleotides used for sequencing. The arrows represent oligonucleo-
tides, pointing in a 5' to 3' direction. Nucleotide number 1 in the
sequence is the A in the first ATG in a 96-kDa open reading frame.
done in 4x SSC (lx SSC is 0.15 M NaCl/0.015 M sodium
citrate, pH 7.0), lx Denhardt's solution (0.02% Ficoll/0.02%
polyvinylpyrrolidone/0.02% bovine serum albumin) at 67°C
for 6 hr. Hybridization was done in 4x SSC/lx Denhardt's
solution/0.1 mg of salmon sperm DNA per ml/0.2% SDS
containing 32P-labeled probe, for 18 hr at 67°C. Blots were
washed twice at room temperature in 2x SSC and once at
410C in 0.1x SSC.
RESULTS
Cloning, Complementation Analysis, and Subcloning. A
genomic DNA fragment containing PRPS was isolated from
a yeast genomic library by complementation of the ts defect
of the yeast prp5 mutant. Of the 17,000 colonies screened, 3
complemented the prpS defect. All plasmids obtained con-
tained the same 9-kb insert according to their restriction
maps; one was selected for all subsequent studies and named
pGD551. The 9-kb insert from pGD551 complements the prpS
ts growth defect when reintroduced into S. cerevisiae SPJ
5.41. The position of the PRPS gene within this insert was
mapped by subcloning a number of overlapping restriction
fragments in centromere-containing vectors and testing for
their ability to complement the prpS defect. The smallest
complementing fragment is 3.0 kb (Fig. 2).
Genetic Mapping by Integrative Transformation. Integra-
tion. A Pvu II-Cla I 5.6-kb complementing fragment was
subcloned in an integrating vector (YIp5). The resulting
plasmid pGD561, containing both the URA3 gene and the
putative PRPS gene, was cut at a unique site within the 5.6-kb
insert, to direct the integration to a homologous locus in the
chromosome (22). A ura3-52, prpS strain, SPJ 5.41, was
transformed with the linearized DNA, resulting in URA+,
temperature-resistant transformants. The site of integration
was confirmed by DNA blot analysis (Fig. 3), using radiola-
beled 5.6-kb Pvu II-Cla I fragment as a probe. A single band
was observed in lanes containing DNA from wild type or
from SPJ 5.41 strains, and two bands, predicted from the
experimental design (22), were observed in those lanes con-
taining DNA from the transformed strain. The results indi-
cate that a single copy of the plasmid was integrated at a
homologous locus and that the cloned DNA represents a
unique sequence in the S. cerevisiae genome. The latter
conclusion was corroborated by other DNA blot analyses in
which different restriction enzymes were used to digest
genomic DNA (not shown).
Tetrad analysis. A diploid strain resulting from a cross
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FIG. 2. Complementation analysis. The horizontal bars represent
DNA fragments that were tested for their ability to complement a
prp5 ts defect and which define the position of the gene. The
fragments, which were cloned in centromere-containing vectors, are
a, the original 9-kb complementing fragment; b, a 5.6-kb Pvu I-Cila
I fragment; c, a 3.0-kb HincIIl-Ca I fragment; d, a 1.7-kb Nhe I-Cla
I fragment; and e, a 5.0-kb Pvu II-Sac I fragment. The arrow f
represents the open reading frame found in the DNA sequence,
positioned relative to the fragments; correspondence to the N and C
termini of the protein is indicated. Fragments a, b, c, and e were
cloned in YCp5O; fragment d was cloned in pSEYC68. Fragments a,
b, and c complement, whereas fragments d and e do not.
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FIG. 3. A blot containing genomic DNA from a wild-type yeast
strain, from strain 5.41, and from strain 5.41 transformed with the
linearized pGD561 was probed with the radiolabeled 5.6-kb Pvu
IIl0a I complementing fragment. Restriction sites B (BstEII), C (Cla
I), P (Pvu II), and Sc (Sac I), the integration site, are present in
pGD551, pGD561, and the chromosome; Sl, (Sal I) is present in
pGD551 and in the chromosome but not in the integrating plasmid
pGD561.
and a wild-type strain, A364A, was sporulated. By tetrad
analysis (15 tetrads), the wild-type, temperature-resistant
phenotype segregated 4:0, the URA3+ phenotype 3:1, and all
other markers were found to segregate as predicted. The
analysis showed that the plasmid was integrated at the PRPS
locus or at a closely linked site rather than at an unlinked
suppressor site. This linkage strongly suggests that the cloned
DNA is indeed the PRPS gene. The 3:1 segregation of the
URA3+ phenotype is due to the presence of URA3 at two
different loci in the parental strains used in the cross: the
URA3 locus in A364A and the site of the integration event in
5.41::pGD561. Crosses of strains combining a wild-type
PRP5 phenotype with a ura3 phenotype to 5.41::pGD561
should result in diploids carrying the URA3 marker only at
the site of integration; however, the diploids obtained did not
sporulate well, and so they were not used for this analysis.
DNA Sequence. The smallest complementing fragment, a
3.0-kb IlincII-Cla I fragment, was entirely sequenced in both
strands as described in Materials and Methods.
An open reading frame that encodes a 96-kb hypothetical
protein is present (Fig. 4A). The first AUG in the open
reading frame is only two codons downstream of an in-frame
stop codon; therefore this is most likely the initiation codon
used.
Translated Protein Sequence. The most noteworthy feature
of the PRP5 protein sequence is a striking resemblance to a
family of RNA helicases known as the D-E-A-D family (Fig.
4B) (15). The helicase most closely resembling PRP5 is p68,
a human nuclear protein (23, 24). PRP5 and p68 are 40%
identical and 63% similar in the region of similarity, which
spans approximately 400 residues of PRP5. Twenty-two of
the 25 residues that are absolutely conserved in all known
RNA helicases are also present in PRP5 at conserved relative
positions (bold in Fig. 4). This 400-residue region of similarity
is a central segment of PRP5 (domain 2) flanked by 260
amino-terminal residues (domain 1) and 189 carboxyl-
terminal residues (domain 3) of unique sequence. These may
represent physically distinct domains unique to PRP5. Do-
mains 1 and 3 are more highly charged than the helicase
domain, with an aspartate + glutamate + histidine + lysine
+ arginine content of42% in domain 1 and 37% in domain 3,
whereas it is 26% in the helicase domain. Relatively high
contents of lysine and glutamate are found in domains 1
(14.8% lysine, 12.2% glutamate) and 3 (14.6% lysine, 11.9o
glutamate), approximately twice that of the helicase domain
(7.2% lysine, 6.7% glutamate). There is a potential nuclear
localization signal (25) at position 90 of the protein sequence,
in the amino-terminal unique sequence domain. Sequences
possibly related to RNA-binding protein motifs (26) occur in
domain 3 at positions 679 and 790. Other motifs present in
nucleic acid binding proteins, including the zinc finger con-
sensus (27), leucine zipper motif (28), and tRNA synthetase
signature sequence (29), are not present in PRP5. No addi-
tional significant similarities have been found.
DISCUSSION
We have cloned a yeast DNA fragment that complements a
prpS ts growth defect and is linked to the PRPS locus. The
cloned DNA therefore probably is the PRP5 gene. Its DNA
sequence contains an open reading frame that encodes a
96-kDa hypothetical protein, which we will refer to as PRP5
hereafter.
PRP5 closely resembles members of a recently identified
family of RNA helicases characterized by several invariant
sequence motifs (15, 30). The characteristic biochemical
activity, ATP-dependent RNA unwinding, has been demon-
strated experimentally in a few of these proteins (31-33).
PRP5 and probably SPP81 are involved in nuclear splicing in
yeast. SPP81, a suppressor of the prp8 mutation, is also a
putative helicase (D. Jamieson and J. Beggs, personal com-
munication). Other putative helicases implicated in RNA
processing are MSS116 (34), which is involved in yeast
mitochondrial splicing, and SPB4, which is involved in rRNA
processing (35).
Special forms of ATP-binding proteins' A (D-X4-A-X4-G-
K-T) and B (D-E-A-D) motifs are among the highly conserved
motifs shared by RNA helicases (36-38). The functions of
various other conserved residues and motifs found at similar
relative positions in all the proteins are not known. PRP5
shares most of the regions of amino acid conservation found
in other RNA helicases, and it has unique sequence segments
at both the amino and carboxyl termini, as do most other
helicases whose entire sequence is known (Fig. 4B) (15).
These unique domains could conceivably tailor the helicases'
activity for their specific functions, providing cellular local-
ization signals and perhaps specific interaction sites.
Three differences between PRP5 and other helicases are
worth noting. (i) An alanine residue at position 6 of the A
motif is thought to be characteristic of RNA helicases, as
distinct from other classes of ATP-binding proteins, in which
a glycine residue is found at that position. The alanine residue
occurs in all known members of the helicase family, except
PRP5 and SPB4, where it is replaced by a serine, which is
similar in size to alanine although more hydrophilic. (ii) The
residues between positions 470 and 495 in the PRP5 trans-
lated sequence represent a spacer region between conserved
regions that diverges in length: it is 9-17 residues longer than
similar regions in other known helicases. This may reflect a
difference in function, or perhaps it marks the position of the
surface of the protein where differences in primary sequence
are tolerated more readily without disruption of tertiary
structure (39). (iii) The sequence Y X H R I G R, conserved
in 13 of 15 helicases known to date, becomes Y X H T T G R
in PRP5, where a charged residue (R) and a hydrophobic
residue (I), are replaced by two smaller, moderately hydro-
philic, residues (T T). The sequence of this conserved region
Proc. Natl. Acad Sci. USA 87 (1990)
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GACATCTGATTAGGGACAATGTTGACTTGAGGACCACGTGAGATTTGAGAAATAGGAAATCTATATGCGA.'ATTCTA.iACCAAGCAAA~,,.LC 6000
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GTAAGCAATTATTATCTCAGAGACTTGGCCTTCAAAAAATTTTTATGAATTGAACATTTCTCGTGTAGAATGGAGTGAGAGCTAGATTATC 7202
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210 220 230 240
GATATATAAAAAAAGGAAAGGTGCCCAACCATCACAAGGGTCCAATGGACTACAAGGACCCAGGTTTAATACGAAAGTTCACTTGGTCCTAA 8404
D N I KI KG TG CP K PVT KW SQLG L STD T MV LI TE KL HYG SL T
250 260 270-
CCTATCATCCCGGCCTTCCGCATTTGTCGGTGTGAGTTTAGGATACAAAACTGCTCGGCAGACATCCCTTCTTTACATTCTAAACAGTAAAG 9606
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CAGTTGTCTATTAGGCACTTTCCGACAACTCGCATTTGCCTAAGGTTTGCTTCCCAAATCATTCGATAATCAAGGGATGGTAAGAAACGTA14404
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GTTGAGAGTTGTGCAAAGCATATATTGTTCAATCAAATATTGGACTCATTCAAAAACTGTAAAGCTGAATGTGCCTGGCTTTCAGCAGTAAC16808
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TATCAGAAGGCTATAACTAGAAAGTCAACGAAAAGAAAGTATCTCTCGTACGAGTTCrCTCAGAGTTAAATTTCCGAGTGTGTTGTTTTATT18000
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AGCTGTCTTGAGAGACTAATCTAGTTTAGATTTACTCCTCTGGTCTAATATTTGTAGTAGTCTAAATTTTGGGGGTATTTAAGATATCAAC26404




B PRP5 (yeast) 260 a&....GLSTDT.MVL . TEKLJWGSLTPIQSQA.L .PAIM4SG .RDVIGISKTG8GKTISYLLPLLRQVKAQRPLSKRETG. .PMWLILAPTRKLA
P618 (human) 77 aa....EANFPANVMDVX.AEQNFTEPTAIQAOG.W.PVALSG.LDMVGVAQTG8SGCTLSYLLPAIVHINHOPFLERGDG... .PICLVLAPTRZLA
EIFA (mouse) 35 aa....DMNLSESLLRGI .YAYGVEKPSAIQQRAIL .PCIK .G .YDVIAOLOSGTCKTATFAISILQOIELDLKA.....TOALVLAPTRZLA
VASA (fruit fly) 248 aa....SADLRDIIIDNV.NKSGYKIPTPIQKCS .X.PVISSG.RDLN4ACAQTGSGKTAAFLLPILSKLLEDPHELEWGR.. .PQVVIVSITRZL&
MSS1 16 (yeast) 109 &a....EGVLDKEIHKAI.TRI4EFPGLTPVQQKT.IIPILSSEDHDVIARAKTGTGMtTAFLIPIFONLINTKFDSOYM... .VKAVrVSPTRDI.&
5P84 (yeast) 10 aa....GFSLLPWIRTGL .DVM4GVETMTPVQAST. I.PMLA.GNKDVVVD8VTSGKgTAAFVIPVLEKVVKEEAN4TSKFKKAHFHSLIIAPTRZLS
SRMB (E. coli) 7 aa....ELELDESLLEAL.QDKGyrTRPTAIQAAA.IPPAL.DG.RDVLGSAPTTGTKTAAYLLPALQHLLDFPRKtKSGP.... .PRILILTPTRZL&
PRP5 LQIHEEVTKFTEADTSIRSV. .CC. .TGGSEI4KKQITDLKRGTE ... . IVVATPQRFIDILTLNDGKLLSTKRITFVVMDEADRIFDL .GEPQITQIMKTV. .RPD...Q
P68 QQVQQVAAEYCRACRLKST.. .CI. .YGGAPKGPQIRDLERGVE .....ICIATPGRLIDrLECGKTNLRRTT.. .YLVWEZADR9U.DM.GrEPQIRKIVDQI. .RPDR .. Q
EIFA QQIQKVVt4ALGDYWGASCHA. .CI....GGTNVRAEVQKLQMEAPH ... IIVCTPGRVVDMLNRRYLSPKYIK.. .MVLDEADR9G.SR .GKDQIYDIFQKL. .NSNT...
VASA IQIFNEARKFAFESYLKIG ....VYGGTSFRHQNECITRGCH.... .VVIATPGRLLDFVDRTFITFEDTR.. .FVIDEADRMLDM.GFSEDMRRIL4THVTMRPEli...
1455116 LQIEAEVKKIHDMNYGLKKYA.CVSLVGGTDFRAANNKM4KLRPN... IVTATPGRLIDVLEKYSNKFFRFVD. .YKVLDEADDRLLET.IaRDDLETISGILNEKNSKSADM
SPB4 RQIESVVLSFEHYPSDLFPIK.C.OLLVGMEATVRDDVSNFLENRPQILIQTPGR1VL~rLQMPAVKTSACS... MIVVMDEADR.LLDM4. S7IKDTEKILRLLPK....Q
SRMB MQVSDHARELAKHTHLDI....ATITGGVAYMIINAEVFSENQD..... IVATTGRLLQYIKEENFDCRAVE. .T.LiLDzaDR14LDm.drAQDIEHIAGETEWR....KQ
PRP5 . .CVLVrSATFPN4KLRSFAVEVLRSPISITINSKGMVNENVKQKFRICHSEDEKFDNLVQLIHERS ... EFFDEVOSENDGQSSDVEEVDAKAXIIFVSSQO1C .DFISKKLLN
P68 . .TLM8ISATWPKEVRQLAEDFLKDYIHINIGALELSANIN .........ZLQIVDVCH.....DVEKDEKLIRLHEEIM4SEKENKTIWFVE .TKRRCDELTRK~RR
EIFA . .VVLLSATt4PSDVLEVTKKFM4RDPIRILVKKEELTLEG..........IRQFYINVER....EEWKWTLCDLYEThTITOAVIVIN .TRRKVDWLTEKI4H
VASA . .TLWrSATFPEEIQRMAGEFLKNYVFVAXGIVGGACSD..........VKQTIYEVN.....KYAKRSKLIEILSEQ.ADGTZVVVE. TKRGADFLASFLSE
1455116 IKLIZATWDDKVOKLANNINNKKECLFLDTVDKN4EPEANER ........DQSVVISEK.FANSIFAAVENIKKQIKERDSNYKAIIFAP .TVKFTSFICSILKN
SPB4 RRTGLrSATMRSAGSDIFKTGLRNPVRITVNSKNOEPSS..........LKLNYCVVNPAEKLQLLVSILNNYKFKKCIVYFPTCVSVSY .FYSFIQYLGKRNIL
SRMB9 . .TLLVSATLEGDAIQDFAERLLEDP .VEVSANPSTRERKK..I.......QWYYRA....DDLEHKTALLVRLLKQPEATRSIVFVR.NKRERVRLELANWLR
PRPS A....IVTCAIHAG.KPYQE. .RLIA. .LEKFKREKNSILI.CTZVLSRG.LNVPEVSLVIXIYNAVKTFAQYVHTTGRtTARGSRSGTAITLL.......... 2 laa
P68 DG. .WPAMG .1K.CDKSQQE .RDWV. .LNEFKHGKAPILIATDVASRG.LDVEDVKFVINYDYPNSSEDYI1IGRITARSTKTGTAYTFF ..........159aa
EIFA R. .DFTVSA.I8I.GD!42QKE .RDVI. .MREFRsGSSRVLITTDLLARGIDVQQVSLVXNYDWPTNR1N!XHIGRGGiNRFGRKGV&INMV.......... 2Oaa
VASA KE. .FPTTS R.GDRLQSQ.REQA. .LRDFKN4GSMKVLIATSVASRCLDIKNIKHXVIVDMSKIDDYVHRIGRTGRVQNGrRATSFF...........58aa
1455116 EFKKDLPILEFK.GKITQNK.RTSL. .VKRFKKDESGILVCTDVGAZGMDFrPNVNEVLQIGVPSELANYIHRI(RT3RSG-KEGSSVLFI..........174aa
SPB4 VN. .EVEIFSIJI.GKL.QTSARTKTLTA .FTDSLSNSVIFTTDVAARGIDIPDVDLVZQL~pPTNTDMEl4IGRC1TGANRVGKAITFL..........232aa
SRMB EAGINNCYLE. .. .GEMVQGK.RNEA.. IKRLTEGRVNVLVATDVAARGIDIPDVSHVTNFDMPRSGDTTIJHRIGOTRTIP.ARKGTAISLV............aa
FIG. 4. (A) Nucleotide sequence of the HincII-Cla I fragment that complements the prpS ts defect. Translation is shown below in single-letter
code. A possible nuclear localization signal at position 90 in the translated protein sequence is underlined. Regions of similarity with RNA
helicase conserved residues are also underlined, and absolutely conserved positions appear in bold characters. The region of alignment with
the RNA helicase family extends approximately from residue 260 to residue 630. (B) Alignment of PRP5 and members of the helicase family
from different species. Conserved residues appear in bold characters.
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also diverges in SPB4. The significance of these differences
is not known. They could define functionally distinct mem-
bers of the helicase family or simply be tolerated changes in
noncrucial residues.
The characteristics of the PRP5 protein sequence suggest
that PRP5 possesses a helicase activity responsible for the
ATP-dependent unwinding of base-paired RNA. Splicing is
ATP dependent, and a number of base-pairing interactions,
such as those between U1 and the 5' splice site, U2 and the
branch point, or U4 and U6, must be formed or resolved
during the course of a splicing reaction (2, 3). Likely, a
helicase directly involved in splicing will participate by con-
verting snRNAs between active and inactive forms, or by
making regions of the pre-mRNA substrate and snRNAs
available or unavailable for base pairing or covalent modifi-
cation. Other PRP proteins have been shown to be integral
snRNP proteins (12, 13). We have no convincing evidence to
indicate that PRP5 is an integral snRNP protein, but the
possibility cannot be rigorously ruled out at this point.
PRP5 acts early in the splicing pathway (2). U2 snRNP
binding, the first step in splicing known' to require ATP
(40-43), requires functional PRP5, whereas Ul snRNP bind-
ing, which occurs prior to U2 binding whether ATP is present
or not (44), does not require functional PRP5 (S. Ruby,
personal communication). One hypothesis is that the putative
PRP5 helicase activity is required for U1, the pre-mRNA
substrate, or U2 to adopt conformations that allow U2
binding. Alternatively, it may be necessary for PRP5 to be
incorporated into the spliceosomal complex prior to U2
binding, but it may carry Qut its activity later in the pathway.
For example, it has been proposed that a highly conserved
region of U6 is involved in catalysis but remains inactive
while base paired to U4 (45). The U4/U6 interaction is
destabilized before or during excision of the 5' exon (40-42,
46), presumably freeing U6 to carry out its'proposed catalytic
function. The U4/U6 helix is stable (47) and is thought to
require an energy-dependent unwinding step to release the
proposed U6 catalytic activity. A helicase such as PRP5 or
SPP81 could carry out this function.
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